(Q35947011)

English

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

phase II clinical trial

0 references

cholangiocarcinoma

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

Edgar Ben-Josef

1

object named as

Edgar Ben-Josef

0 references

Steven R Alberts

8

object named as

Steven R Alberts

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Katherine A Guthrie

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Anthony B El-Khoueiry

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Christopher L Corless

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mark M Zalupski

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Andrew M Lowy

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Charles R Thomas

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Laura A Dawson

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Kenneth C Micetich

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Melanie B Thomas

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Abby B Siegel

12

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Charles D Blanke

13

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

11 May 2015

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

24

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

2617-2622

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

External-beam radiotherapy for localized extrahepatic cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Predictors of long-term survival in patients with gallbladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Improved survival in resected biliary malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Gallbladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

2 October 2017

Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

11 July 2018

Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

11 July 2018

Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4534524

24 September 2018

The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25964250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2014.60.2219

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35947011&oldid=1968634959"